MDL | MFCD00016873 |
---|---|
Molecular Weight | 198.22 |
Molecular Formula | C10H14O4 |
SMILES | OCC(O)COC1=CC=CC=C1OC |
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT01202279 | Reckitt Benckiser Inc.|Reckitt Benckiser LLC |
Acute Upper Respiratory Track Infection
|
October 2009 | Phase 4 |
NCT01364467 | Virginia Commonwealth University|Pfizer |
Chronic Rhinitis
|
May 2011 | Phase 2 |
NCT02879981 | Hoffmann-La Roche |
Bronchitis
|
November 10, 2016 | |
NCT02902640 | Hoffmann-La Roche |
Bronchitis
|
November 15, 2016 | |
NCT01576809 | Novartis|Novartis Consumer Health |
Upper Respiratory Infections
|
March 2012 | Phase 3 |
NCT00377403 | Washington University School of Medicine|National Institute of Allergy and Infectious Diseases (NIAID) |
Acute Respiratory Infections|Acute Rhinosinusitis
|
October 2006 | Phase 4 |
NCT01562548 | GlaxoSmithKline |
Upper Back Pain
|
February 2012 | Not Applicable |
NCT01062256 | Wyeth is now a wholly owned subsidiary of Pfizer |
Infection
|
January 2010 | Not Applicable |
NCT03706300 | Dr. Reddy´s Laboratories Limited |
Healthy
|
December 2014 | Phase 1 |
NCT01119534 | Azidus Brasil |
Cough
|
May 2011 | Phase 3 |
NCT01257243 | EMS |
Cough
|
October 1, 2012 | Phase 3 |
NCT00000752 | National Institute of Allergy and Infectious Diseases (NIAID)|Adams Laboratories|Glaxo Wellcome |
HIV Infections|Sinusitis
|
Phase 2 | |
NCT03213353 | Johnson & Johnson Consumer and Personal Products Worldwide |
Bioequivalence|Healthy Volunteers
|
July 3, 2017 | Phase 1 |
NCT01046136 | Reckitt Benckiser Inc.|Reckitt Benckiser LLC |
Common Cold
|
December 2009 | Phase 2 |
NCT02069665 | Liaoning University of Traditional Chinese Medicine|Beijing University of Chinese Medicine |
Pneumonia
|
December 2011 | Not Applicable |
NCT01085721 | Mantecorp Industria Quimica e Farmaceutica Ltd. |
Viral Infections of the Upper Respiratory Tract
|
Phase 3 | |
NCT01537081 | Reckitt Benckiser LLC |
Acute Upper Respiratory Tract Infection
|
September 2011 | Phase 2|Phase 3 |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 100 mg/mL ( 504.49 mM ; Need ultrasonic and warming)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 5.0449 mL | 25.2245 mL | 50.4490 mL |
5 mM | 1.0090 mL | 5.0449 mL | 10.0898 mL |
10 mM | 0.5045 mL | 2.5224 mL | 5.0449 mL |